The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha- pregnan-20-one
Abstract
The relationship between symptoms of premenstrual syndrome (PMS) and serum levels of pregnenolone (Pe), pregnenolone sulfate (PS), 5 alpha-pregnane-3,20-dione (5 alpha-DHP), 3 alpha-hydroxy-5 alpha- pregnan-20-one (5 alpha-THP), LH, 17 beta-estradiol (E2), and progesterone (P) was investigated during 2 consecutive menstrual cycles in 12 patients using daily measurements. Corresponding hormones were also measured during 1 cycle in 8 control women. Pe, PS, 5 alpha-DHP, and 5 alpha-THP showed a significant cyclicity within menstrual cycles and a high rate of correlation with P variation in both PMS patients and controls. No significant difference was found between PMS patients and controls in average serum concentrations of Pe, PS, 5 alpha-DHP, 5 alpha-THP, and LH during the luteal phase, whereas a significantly higher level of E2 and a lower level of P were observed in PMS patients. The variation in symptom scores was compared with that in hormone levels within each woman. The symptom peak showed a delay of 3-4 days after the serum P, Pe, 5 alpha-DHP, and 5 alpha-THP peaks. However, the plasma PS peak appeared on the same day or only 1 day before the symptom peak in PMS patients. When comparing the 2 cycles studied, more negative symptoms occurred in cycles with higher luteal phase E2, Pe, and PS concentrations, whereas higher luteal phase 5 alpha-DHP and 5 alpha-THP concentrations were associated with improved symptom ratings in PMS patients. These results suggest that the mentioned steroids are related to the severity of distressing symptoms in PMS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it
Flood, J. F., Morley, J. E., & Roberts, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1567 · Cited by 436
Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain?
Dorota Majewska, M., & Schwartz, R. D. (1987) · Brain Research · doi:10.1016/0006-8993(87)91394-1 · Cited by 330
Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons
Majewska, M. D., Mienville, J.-M., & Vicini, S. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90202-9 · Cited by 270
Backstrom, T., Sanders, D., Leask, R., Davidson, D., Warner, P., & Bancroft, J. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198312000-00004 · Cited by 266
Modulation of the GABAA receptor by progesterone metabolites
Callachan, H., Cottrell, G. A., Hather, N. Y., Lambert, J. J., Nooney, J. M., & Peters, J. A. (1987) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1987.0049 · Cited by 252
Levels of prostaglandins in human endometrium during the normal menstrual cycle
Downie, J., Poyser, N. L., & Wunderlich, M. (1974) · The Journal of Physiology · doi:10.1113/jphysiol.1974.sp010446 · Cited by 219
Schmidt, P. J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.5.1256 · Cited by 184
Mienville, J.-M., & Vicini, S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90024-3 · Cited by 182
Estrogen and progesterone in plasma in relation to premenstrual tension
Bäckström, T. C., & Carstensen, H. (1974) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(74)90139-3 · Cited by 158
Pregnenolone, dehydroepiandrosterone, and their sulfate and fatty acid esters in the rat brain
Jo, D.-H., Abdallah, M. A., Young, J., Baulieu, É.-É., & Röbel, P. (1989) · Steroids · doi:10.1016/0039-128x(89)90003-2 · Cited by 119
Cited by
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa
Otto, B., Cuntz, U., Fruehauf, E., Wawarta, R., Folwaczny, C., Riepl, R., Heiman, M., Lehnert, P., Fichter, M., & Tschop, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje-1450669 · Cited by 689
Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E., & Guidotti, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3239 · Cited by 672
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives
Rupprecht, R., & Holsboer, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01399-5 · Cited by 633
Hormones and mood: from menarche to menopause and beyond
Steiner, M. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00432-9 · Cited by 558
Neurosteroid metabolism in the human brain
Stoffel-Wagner, B. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450669 · Cited by 538
Estrogen–serotonin interactions: implications for affective regulation
Rubinow, D. R., Schmidt, P. J., & Roca, C. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00162-0 · Cited by 505
Effects of Antidepressant Treatment on Neuroactive Steroids in Major Depression
Romeo, E., Ströhle, A., Spalletta, G., Michele, F. D., Hermann, B., Holsboer, F., Pasini, A., & Rupprecht, R. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.910 · Cited by 463
Concas, A., Mostallino, M. C., Porcu, P., Follesa, P., Barbaccia, M. L., Trabucchi, M., Purdy, R. H., Grisenti, P., & Biggio, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13284 · Cited by 421
How to study the menstrual cycle: Practical tools and recommendations
Schmalenberger, K. M., Tauseef, H. A., Barone, J. C., Owens, S. A., Lieberman, L., Jarczok, M. N., Girdler, S. S., Kiesner, J., Ditzen, B., & Eisenlohr-Moul, T. A. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104895 · Cited by 404
Epperson, C. N., Haga, K., Mason, G. F., Sellers, E., Gueorguieva, R., Zhang, W., Weiss, E., Rothman, D. L., & Krystal, J. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.851 · Cited by 399
Circulating Levels of Allopregnanolone in Humans: Gender, Age, and Endocrine Influences
Genazzani, A. R., Petraglia, F., Bernardi, F., Casarosa, E., Salvestroni, C., Tonetti, A., Nappi, R. E., Luisi, S. V., Palumbo, M. A., Purdy, R. H., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2099 · Cited by 393
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387
Perimenopause: The Complex Endocrinology of the Menopausal Transition
Prior, J. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0341 · Cited by 364
Premenstrual dysphoric disorder: Evidence for a new category for DSM-5
Epperson, C. N., Steiner, M., Hartlage, S. A., Eriksson, E., Schmidt, P. J., Jones, I., & Yonkers, K. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081302 · Cited by 361
The influence of subunit composition on the interaction of neurosteroids with GABAA receptors
Belelli, D., Casula, A., Ling, A., & Lambert, J. J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00172-7 · Cited by 334
Uzunov, D. P., Cooper, T. B., Costa, E., & Guidotti, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12599 · Cited by 330
The etiology, biology, and evolving pathology of premenstrual syndromes
Halbreich, U. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00097-0 · Cited by 306
Progesterone selectively increases amygdala reactivity in women
van Wingen, G. A., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Bäckström, T., Buitelaar, J. K., & Fernández, G. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002030 · Cited by 273
“18 which mimics the low allopregnanolone levels during the human follicular phase”
BackgroundSelf-citationAllopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder
Girdler, S. S., Straneva, P. A., Light, K. C., Pedersen, C. A., & Morrow, A. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01044-1 · Cited by 267
Wang, J. M., Johnston, P. B., Ball, B. G., & Brinton, R. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4520-04.2005 · Cited by 261
Steroids, neuroactive steroids and neurosteroids in psychopathology
Dubrovsky, B. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.001 · Cited by 250
Shechter, A., & Boivin, D. B. (2010) · International Journal of Endocrinology · doi:10.1155/2010/259345 · Cited by 194
Allopregnanolone concentrations and premenstrual syndrome
Monteleone, P., Luisi, S., Tonetti, A., Bernardi, F., Genazzani, A., Luisi, M., Petraglia, F., & Genazzani, A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420269 · Cited by 186
Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle
Ossewaarde, L., Hermans, E. J., van Wingen, G. A., Kooijman, S. C., Johansson, I.-M., Bäckström, T., & Fernández, G. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.011 · Cited by 185
Sundström, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., & Bäckström, T. (1998) · Neuroendocrinology · doi:10.1159/000054307 · Cited by 182
Self-citationBäckström, T., Haage, D., Löfgren, M., Johansson, I. M., Strömberg, J., Nyberg, S., Andréen, L., Ossewaarde, L., van Wingen, G. A., Turkmen, S., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.061 · Cited by 169
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy
Reddy, D. S. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.017 · Cited by 167
Structural and functional biology of aldo-keto reductase steroid transforming enzymes
Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164
Neurosteroids in the context of stress: implications for depressive disorders
Girdler, S. S., & Klatzkin, R. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.006 · Cited by 148
Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
Ratner, M. H., Kumaresan, V., & Farb, D. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00169 · Cited by 96
Pregnenolone sulfate: from steroid metabolite to TRP channel ligand
Harteneck, C. (2013) · Molecules · doi:10.3390/molecules181012012 · Cited by 89
MacKenzie, G., & Maguire, J. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3423-z · Cited by 84
“…allopregnanolone is synthesized in the corpus luteum peaking in the luteal phase with serum levels reaching up to 4 nmol/l compared to <1 nmol/l in the follicular phase (Andreen et al. 2009; Bicikova et al. 1998; Genazzani et al. 1998; Monteleone et al. 2000; Purdy et al. 1990; Wang et al. 1996).”
Gangisetty, O., & Reddy, D. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.037 · Cited by 84
Hardoy, M. C., Serra, M., Carta, M. G., Contu, P., Pisu, M. G., & Biggio, G. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000229483.52955.ec · Cited by 80
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Kaura, V., Ingram, C. D., Gartside, S. E., Young, A. H., & Judge, S. J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.006 · Cited by 44
Löfgren, M., Johansson, I.-M., Meyerson, B., Turkmen, S., & Bäckström, T. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.08.015 · Cited by 29
Self-citationKoonce, C. J., & Frye, C. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.025 · Cited by 23
Metadata
- Authors
- Wang, M.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1996-03-01
- Volume
- 81
- Issue
- 3
- Pages
- 1076-1082
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2029466154
- Cited by
- 353
- References
- 13
- FWCI
- 16.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.